Trial Profile
A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Adocia
- 16 Dec 2016 Primary endpoint has been met. (Pharmacodynamics: AUCBG 0-2h), as reported in an Eli Lilly media release.
- 16 Dec 2016 Results published in the an Eli Lilly Media Release
- 16 Dec 2016 Primary endpoint has been met. (Pharmacokinetics: AUClis 0-30min), as reported in an Eli Lilly media release.